First test of new Parkinson's pill in healthy people
NCT ID NCT06088784
Summary
This was an early safety study to see how healthy adults tolerate a new oral drug called ATH-399A. Researchers tested single and multiple doses in 76 healthy volunteers to check for side effects and see how the body absorbs and processes the drug. The goal is to gather information to develop this as a future treatment for Parkinson's Disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Syneos Quebec Canada
Québec, QC G1P 0A2, Canada
Conditions
Explore the condition pages connected to this study.